Biotechnology and society in Cuba: the case of the Molecular Immunology Center
since the 1980s, effective and sustained policies in the field of biotechnology have been pursued in Cuba. The highest priority has been given to the medical-pharmaceutical industry (medicine production, vaccines, monoclonal compounds, among others). This process...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Tecnológico Metropolitano - ITM
2014-08-01
|
| Series: | Trilogía Ciencia Tecnología Sociedad |
| Subjects: | |
| Online Access: | https://revistas.itm.edu.co/index.php/trilogia/article/view/432/pdf_7 |
| Summary: | since the 1980s, effective and sustained policies in the field of biotechnology have been pursued in Cuba. The highest priority has been given to the medical-pharmaceutical industry (medicine production, vaccines, monoclonal compounds, among others). This process intended to satisfy demands of Cuban health system and to generate high value products that were able to compete in the world market. This paper comes closer to the Cuban experience through the specific case of one of its more successful centers: the Molecular Immunology Center.The experiences of this center not only reflect the Cuban strategy in the field of biotechnology but also its bonds with national policies, economy and society, and fundamental breakthroughs and challenges. The document deals with these victories, looking at them from its interrelations with Cuban policies and economic challenges imposed by the international regulatory framework. All things considered, the document seeks to contribute, from the analysis of the advances, difficulties and challenges of Cuban experience, to the generation of good lessons in the S&T policy decision-making field and to encourage the development of high technology industries in developing countries. |
|---|---|
| ISSN: | 2145-4426 2145-7778 |